Tumor cells in NKCL were consistently negative for CD3, CD4, and CD5 and showed moderate CD2, CD38, CD56, and CD94 and heterogeneous expressions of CD7, CD8, CD16, and CD26. The gene discussed is CD5; the disease is neoplasm.